热门资讯> 正文

4D分子治疗公司聘请克里斯蒂安·Humer担任首席财务官

2025-11-17 19:17

4D Molecular Therapeutics (FDMT) has appointed Kristian Humer as chief financial officer.
Humer is a seasoned finance executive and biotechnology leader with more than two decades of experience, including at Citi, Foghorn Therapeutics, and Viridian Therapeutics.
Source: Press Release

More on 4D Molecular Therapeutics

4D Molecular Therapeutics: This Gene Therapy Company May Soon Surprise Investors
4D Molecular Therapeutics, Inc. (FDMT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
4D Molecular Therapeutics stock rises after pricing $100M offering
Seeking Alpha’s Quant Rating on 4D Molecular Therapeutics
Historical earnings data for 4D Molecular Therapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。